CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C09204 | BRD-K21483310 | BRD-K21483310 | -- | -- | -- | Details |
| C09205 | BRD-K21483524 | BRD-K21483524 | -- | -- | -- | Details |
| C09206 | BRD-K21494224 | BRD-K21494224 | -- | -- | -- | Details |
| C09207 | BRD-K21498052 | BRD-K21498052 | -- | -- | -- | Details |
| C09208 | BRD-K21498250 | BRD-K21498250 | -- | -- | -- | Details |
| C09209 | BRD-K21501851 | BRD-K21501851 | -- | -- | -- | Details |
| C09210 | BRD-K21503128 | BRD-K21503128 | -- | -- | -- | Details |
| C09211 | BRD-K21509488 | BRD-K21509488 | -- | -- | -- | Details |
| C09212 | BRD-K21509725 | BRD-K21509725 | -- | -- | -- | Details |
| C09213 | BRD-K21516480 | BRD-K21516480 | -- | -- | -- | Details |
| C09214 | BRD-K21517000 | BRD-K21517000 | -- | -- | -- | Details |
| C09215 | BRD-K21520694 | sulfacetamide | -- | -- | -- | Details |
| C09216 | BRD-K21528100 | BRD-K21528100 | -- | -- | -- | Details |
| C09217 | BRD-K21532219 | UMB-32 | -- | -- | -- | Details |
| C09218 | BRD-K21533599 | BRD-K21533599 | -- | -- | -- | Details |
| C09219 | BRD-K21535473 | BRD-K21535473 | -- | -- | -- | Details |
| C09220 | BRD-K21536131 | BRD-K21536131 | -- | -- | -- | Details |
| C09221 | BRD-K21537090 | BRD-K21537090 | -- | -- | -- | Details |
| C09222 | BRD-K21539100 | BRD-K21539100 | -- | -- | -- | Details |
| C09223 | BRD-K21544408 | BRD-K21544408 | -- | -- | -- | Details |
| C09224 | BRD-K21546432 | BRD-K21546432 | -- | -- | -- | Details |
| C09225 | BRD-K21547160 | sufentanil | OPRM1 | Opiod receptor modulator | -- | Details |
| C09226 | BRD-K21547311 | BRD-K21547311 | -- | -- | -- | Details |
| C09227 | BRD-K21547369 | BRD-K21547369 | -- | -- | -- | Details |
| C09228 | BRD-K21548250 | moracizine | SCN5A | Sodium channel blocker | -- | Details |
| C09229 | BRD-K21549522 | BRD-K21549522 | -- | -- | -- | Details |
| C09230 | BRD-K21558506 | BRD-K21558506 | -- | -- | -- | Details |
| C09231 | BRD-K21565985 | xylazine | -- | -- | -- | Details |
| C09232 | BRD-K21568472 | BRD-K21568472 | -- | -- | -- | Details |
| C09233 | BRD-K21569926 | BRD-K21569926 | -- | -- | -- | Details |
| C09234 | BRD-K21572481 | SA-1456039 | -- | -- | -- | Details |
| C09235 | BRD-K21576808 | BRD-K21576808 | -- | -- | -- | Details |
| C09236 | BRD-K21579116 | BRD-K21579116 | -- | -- | -- | Details |
| C09237 | BRD-K21582416 | BRD-K21582416 | -- | -- | -- | Details |
| C09238 | BRD-K21584435 | BRD-K21584435 | -- | -- | -- | Details |
| C09239 | BRD-K21588993 | BRD-K21588993 | -- | -- | -- | Details |
| C09240 | BRD-K21590495 | BRD-K21590495 | -- | -- | -- | Details |
| C09241 | BRD-K21595913 | BRD-K21595913 | -- | -- | -- | Details |
| C09242 | BRD-K21600166 | BRD-K21600166 | -- | -- | -- | Details |
| C09243 | BRD-K21610715 | BRD-K21610715 | -- | -- | -- | Details |
| C09244 | BRD-K21614065 | BRD-K21614065 | -- | -- | -- | Details |
| C09245 | BRD-K21620541 | BRD-K21620541 | -- | -- | -- | Details |
| C09246 | BRD-K21622447 | BRD-K21622447 | -- | -- | -- | Details |
| C09247 | BRD-K21626096 | BRD-K21626096 | -- | -- | -- | Details |
| C09248 | BRD-K21627123 | BRD-K21627123 | -- | -- | -- | Details |
| C09249 | BRD-K21629388 | BRD-K21629388 | -- | -- | -- | Details |
| C09250 | BRD-K21630495 | BRD-K21630495 | -- | -- | -- | Details |
| C09251 | BRD-K21635266 | BRD-K21635266 | -- | -- | -- | Details |
| C09252 | BRD-K21635943 | BRD-K21635943 | -- | -- | -- | Details |
| C09253 | BRD-K21635957 | BRD-K21635957 | -- | -- | -- | Details |
| C09254 | BRD-K21636276 | SA-90024 | -- | -- | -- | Details |
| C09255 | BRD-K21640605 | BRD-K21640605 | -- | -- | -- | Details |
| C09256 | BRD-K21642343 | BRD-K21642343 | -- | -- | -- | Details |
| C09257 | BRD-K21642579 | BRD-K21642579 | -- | -- | -- | Details |
| C09258 | BRD-K21643869 | BRD-K21643869 | -- | -- | -- | Details |
| C09259 | BRD-K21648400 | BRD-K21648400 | -- | -- | -- | Details |
| C09260 | BRD-K21652416 | BRD-K21652416 | -- | -- | -- | Details |
| C09261 | BRD-K21658057 | BRD-K21658057 | -- | -- | -- | Details |
| C09262 | BRD-K21660570 | BRD-K21660570 | -- | -- | -- | Details |
| C09263 | BRD-K21660676 | BRD-K21660676 | -- | -- | -- | Details |
| C09264 | BRD-K21662756 | BRD-K21662756 | -- | -- | -- | Details |
| C09265 | BRD-K21665449 | BRD-K21665449 | -- | -- | -- | Details |
| C09266 | BRD-K21667562 | AM-404 | TRPV1 | FAAH inhibitor; TRPV antagonist; Cyclooxygenase inhibitor | -- | Details |
| C09267 | BRD-K21668646 | BRD-K21668646 | -- | -- | -- | Details |
| C09268 | BRD-K21670884 | cariporide | -- | -- | -- | Details |
| C09269 | BRD-K21671578 | BRD-K21671578 | -- | -- | -- | Details |
| C09270 | BRD-K21672174 | Ro-28-1675 | GCK | Glucokinase activator | -- | Details |
| C09271 | BRD-K21672423 | BRD-K21672423 | -- | -- | -- | Details |
| C09272 | BRD-K21678546 | BRD-K21678546 | -- | -- | -- | Details |
| C09273 | BRD-K21680192 | mitoxantrone | TOP2A | Topoisomerase inhibitor | -- | Details |
| C09274 | BRD-K21682170 | BRD-K21682170 | -- | -- | -- | Details |
| C09275 | BRD-K21683465 | BRD-K21683465 | -- | -- | -- | Details |
| C09276 | BRD-K21683946 | BRD-K21683946 | -- | -- | -- | Details |
| C09277 | BRD-K21690323 | BRD-K21690323 | -- | -- | -- | Details |
| C09278 | BRD-K21691498 | BRD-K21691498 | -- | -- | -- | Details |
| C09279 | BRD-K21695872 | BRD-K21695872 | -- | -- | -- | Details |
| C09280 | BRD-K21699764 | BRD-K21699764 | -- | -- | -- | Details |
| C09281 | BRD-K21704309 | BRD-K21704309 | -- | -- | -- | Details |
| C09282 | BRD-K21707058 | BRD-K21707058 | -- | -- | -- | Details |
| C09283 | BRD-K21709199 | BRD-K21709199 | -- | -- | -- | Details |
| C09284 | BRD-K21713052 | BRD-K21713052 | -- | -- | -- | Details |
| C09285 | BRD-K21718444 | KW-2449 | FGFR1; FLT3; ABL1; AURKA | FLT3 inhibitor; Abl kinase inhibitor; Aurora kinase inhibitor | -- | Details |
| C09286 | BRD-K21728777 | AMG-900 | -- | -- | -- | Details |
| C09287 | BRD-K21728898 | BRD-K21728898 | -- | -- | -- | Details |
| C09288 | BRD-K21729626 | BRD-K21729626 | -- | -- | -- | Details |
| C09289 | BRD-K21732483 | BRD-K21732483 | -- | -- | -- | Details |
| C09290 | BRD-K21733600 | rofecoxib | PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C09291 | BRD-K21740361 | BRD-K21740361 | -- | -- | -- | Details |
| C09292 | BRD-K21741022 | BRD-K21741022 | -- | -- | -- | Details |
| C09293 | BRD-K21743103 | BRD-K21743103 | -- | -- | -- | Details |
| C09294 | BRD-K21747676 | BRD-K21747676 | -- | -- | -- | Details |
| C09295 | BRD-K21747841 | BRD-K21747841 | -- | -- | -- | Details |
| C09296 | BRD-K21751020 | BRD-K21751020 | -- | -- | -- | Details |
| C09297 | BRD-K21753319 | BRD-K21753319 | -- | -- | 3-chloro-4-(isopropylsulfonyl)-2-thiophenecarbohydrazide | Details |
| C09298 | BRD-K21759602 | BRD-K21759602 | -- | -- | -- | Details |
| C09299 | BRD-K21765169 | BRD-K21765169 | -- | -- | -- | Details |
| C09300 | BRD-K21771449 | BRD-K21771449 | -- | -- | -- | Details |
| C09301 | BRD-K21771537 | BRD-K21771537 | -- | -- | -- | Details |
| C09302 | BRD-K21773564 | BRD-K21773564 | -- | -- | -- | Details |
| C09303 | BRD-K21784579 | BRD-K21784579 | -- | -- | -- | Details |